series-c-plus
Stage
1
Investors
About
Llusern Scientific develops rapid point-of-care molecular diagnostic solutions, primarily focusing on urinary tract infection (UTI) testing. Their flagship product, Lodestar DX, delivers accurate bacterial identification within 35 minutes, enabling targeted therapy and reducing unnecessary antibiotic prescriptions.
Explore Llusern Scientific's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.